Find Denopamine manufacturers, exporters & distributors on PharmaCompass

Denopamine

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 JDMF

1 API Suppliers
1 JDMF

MARKET PLACE

1 APIs

marketPlace
1 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 71771-90-9, R(-)-denopamine, Kalgut, Ta 064, Ta-064, 4-[(1r)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol

Molecular Formula

C₁₈H₂₃NO₄

Molecular Weight

317.4 g/mol

InChI Key

VHSBBVZJABQOSG-INIZCTEOSA-N

FDA UNII

V5F60UPD8P

1 2D Structure

Denopamine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4-[(1R)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol

2.1.2 InChI

InChI=1S/C18H23NO4/c1-22-17-8-3-13(11-18(17)23-2)9-10-19-12-16(21)14-4-6-15(20)7-5-14/h3-8,11,16,19-21H,9-10,12H2,1-2H3/t16-/m0/s1

2.1.3 InChI Key

VHSBBVZJABQOSG-INIZCTEOSA-N

2.1.4 Canonical SMILES

COC1=C(C=C(C=C1)CCNCC(C2=CC=C(C=C2)O)O)OC

2.1.5 Isomeric SMILES

COC1=C(C=C(C=C1)CCNC[C@@H](C2=CC=C(C=C2)O)O)OC

2.2 Other Identifiers

2.2.1 UNII

V5F60UPD8P

2.3 Synonyms

2.3.1 MeSH Synonyms

1. (3,4-dimethoxyphenethylaminomethyl)-4-hydroxybenzyl Alcohol

2. 1-(p-hydroxyphenyl)-2-((3,4-dimethoxyphenethyl)amino)ethanol

3. Ta 064

4. Ta-064

2.3.2 Depositor-Supplied Synonyms

1. 71771-90-9

2. R(-)-denopamine

3. Kalgut

4. Ta 064

5. Ta-064

6. 4-[(1r)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol

7. V5f60upd8p

8. Chembl493682

9. Denopamina

10. Denopaminum

11. 4-[(1r)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxy-ethyl]phenol

12. Benzenemethanol, A-[[[2-(3,4-dimethoxyphenyl)ethyl]amino]methyl]-4-hydroxy-,(ar)-

13. Denopaminum [latin]

14. Kalgut (tn)

15. Denopamina [spanish]

16. Denopamine [inn:jan]

17. Unii-v5f60upd8p

18. R()-denopamine

19. Ncgc00094384-01

20. Denopamine [mi]

21. Denopamine (jan/inn)

22. Denopamine [inn]

23. Denopamine [jan]

24. Lopac-d-7815

25. Denopamine [mart.]

26. Denopamine [who-dd]

27. Dsstox_cid_25800

28. Dsstox_rid_81138

29. Dsstox_gsid_45800

30. Gtpl534

31. Schembl218640

32. Dtxsid8045800

33. Chebi:135359

34. Bcp17423

35. Zinc1552175

36. Tox21_111272

37. Bdbm50252956

38. (-)-(r)-1-(p-hydroxyphenyl)-2-((3,4-dimethoxyphenethyl)amino)ethanol

39. Benzenemethanol, Alpha-(((2-(3,4-dimethoxyphenyl)ethyl)amino)methyl)-4-hydroxy-, (r)-

40. Ncgc00015367-01

41. Cas-71771-90-9

42. Hy-119515

43. Cs-0068617

44. R(-)-denopamine, >=98% (hplc), Powder

45. D02614

46. Dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol

47. (r)-4-(2-(3,4-dimethoxyphenethylamino)-1-hydroxyethyl)phenol

48. 4-[(1r)-2-[2-(3,4-

49. 4-[(1r)-2-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-1-hydroxyethyl]phenol

50. (-)-(r)-.alpha.-(((3,4-dimethoxyphenethyl)amino)methyl)-p-hydroxybenzyl Alcohol

51. (-)-(r)-alpha-(((3,4-dimethoxyphenethyl)amino)methyl)-p-hydroxybenzyl Alcohol

2.4 Create Date

2005-12-16

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₂₃NO₄
Molecular Weight	317.4 g/mol
XLogP3	1.8
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	8
Exact Mass	317.16270821 g/mol
Monoisotopic Mass	317.16270821 g/mol
Topological Polar Surface Area	71 Å²
Heavy Atom Count	23
Formal Charge	0
Complexity	320
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Cardiotonic Agents

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)

Adrenergic beta-Agonists

Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)

API SUPPLIERS